OCT 23, 2026 · JOURNAL ARTICLE
From Passive Carriers to Niche Engineers: The Evolving Paradigm of Engineered Bacteria in Cancer Therapy
Pharmaceutics
Engineered bacterial systems have been predominantly conceptualized as living drug-delivery vehicles, with their therapeutic value attributed primarily to tumor-homing capabilities